Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Topical minoxidil effectively and safely treats extensive alopecia areata but doesn't change its course.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

Minoxidil doesn't affect perifollicular lymphoid infiltration in alopecia areata patients.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Topical anthralin helped regrow hair in mice with a condition similar to human alopecia.

Biomaterials with MSC-derived substances could improve tissue repair and have advantages over direct cell therapy.

Edible seeds from the Cucurbitaceae family like pumpkin and watermelon seeds are nutritious and may have health benefits, but eating too much can cause side effects.

Early diagnosis and treatment are crucial for preventing permanent hair loss in various scalp conditions, and while new treatments are promising, more research is needed to evaluate their effectiveness.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

Zinc helps manage skin disorders and deficiencies can worsen some conditions.

Stress may affect hair growth by influencing hair follicle development and could contribute to hair loss.

Topical immunotherapy is still effective for managing alopecia areata, even with new treatments available.

Umbilical cord and cord blood stem cells are promising for treating chronic diseases due to their versatility and ethical acceptability.

MSC-derived exosomes can help treat COVID-19, hair loss, skin aging, and arthritis.

No cure exists for alopecia areata, and treatments are personalized.

Using anthralin and calcipotriene together might help treat tough cases of alopecia areata, but more research is needed to understand how it works.

Laser and light therapies, especially the 308 nm excimer laser, are effective and safe for treating alopecia areata, but more research is needed.

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Tofacitinib may slow hair loss in scarring alopecias but is unlikely to regrow significant hair.

In 2024, the FDA approved 50 new drugs, including treatments for hair loss, anemia, high blood pressure, and Alzheimer's.

The document summarizes recent dermatological treatments and advances in areas like pediatric care, wound healing, skin closure, light-based therapies, pigment disorders, hair loss, immunotherapy, infection management, melanoma, drug reactions, and facial rejuvenation.

Chemotherapy causes hair loss by damaging hair follicles and stem cells, with more research needed for prevention and treatment.

Korean Red Ginseng has beneficial components that help with stress, immunity, fatigue, memory, blood flow, and disease protection.

Both mouse and rat models are effective for testing alopecia areata treatments.

Despite progress in treatment, the exact cause of Alopecia areata is still unknown.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.